SCHEMBL19207342

SCHEMBL19207342

O=C(O)c1ccc2c(c1)ON=CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA4 P22748 2/20 0.41
CA9 Q16790 2/20 0.41
TDP1 Q9NUW8 3/20 0.40
SRD5A2 P31213 5/20 0.39
TDP2 O95551 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 2/20 0.36
GAA P10253 1/20 0.36
CA6 P23280 1/20 0.36
PTGS2 P35354 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SRD5A1 P18405 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3712693 0.87 TDP1 (0.46) ALDH1A1MAPK1CA12CA1CA2
SCHEMBL5586035 0.85 TSHR (0.47) ALDH1A1MAPK1KDM4ETSHR
Hydrochloric Acid SCHEMBL10700892 0.85 TDP1 (0.45) ALDH1A1MAPK1CA12CA1CA2
SCHEMBL9995987 0.72 TSHR (0.47) ALDH1A1KDM4ETSHR
SCHEMBL10509462 0.72 NPC1 (0.46) TDP1KDM4EMAPTPOLBMEN1
SCHEMBL1246502 0.72 AHR (0.39) MAPTBLM
SCHEMBL5765610 0.71 ALDH1A1 (0.47) ALDH1A1MAPK1CA12CA1CA2
Carbamic Acid SCHEMBL6649969 0.71 HSD17B10 (0.34) ALDH1A1MAPK1TDP1KDM4EMAPT
SCHEMBL5138970 0.70 ALDH1A1 (0.47) ALDH1A1MAPK1CA12CA1CA2
SCHEMBL10974858 0.70 ALDH1A1 (0.46) ALDH1A1MAPK1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3411080-A2 COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES Arrakis Therapeutics, Inc. (US) 2018-12-12 EP disclosed
WO-2017136450-A2 COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES ARRAKIS THERAPEUTICS, INC. (US) 2017-08-10 WO disclosed